A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(10 sites)

United States

Midland Florida Clinical Research Center, DeLand, Florida

Pharmakon Medical Research, Palm Beach Gardens, Florida

Vital Medical Research, Sweetwater, Florida

EMbassy Research Network, Bloomfield Township, Michigan

US Foot and Ankle Specialists-Cary Satellite Site, Cary, North Carolina

US Foot and Ankle Specialists, Raleigh, North Carolina

US Foot and Ankle Specialists, Blue Ash, Ohio

Lower Extremity Institute for Research and Therapy, Boardman, Ohio

Perfizien Clinical Research, LLC., Houston, Texas

Foot and Ankle Specialists of the Mid-Atlantic, Salem, Virginia